insurer coverage glp-1 news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs CMS has announced important updates

is approved for weight loss in adults and children ages 12 and over with obesity, and for adults with overweight plus at least one weight-related condition (such as type 2 diabetes or heart disease)

Are you finding that there's brain fog and you need afternoon naps every day

For women experiencing menopause-related weight gain , semaglutide can be particularly effective since it targets the metabolic slowdown and appetite dysregulation common during hormonal transitions

A balanced diet rich in vegetables, lean protein, wholegrains, and healthy fats supports both lipid profiles and follicle function

A recent 20-week, phase II trial investigated the effects of subcutaneous administration of semaglutide 2.4 mg on gastric emptying, appetite, and energy intake in patients with obesity

In patients with type-2 diabetes, glucagon AUC was significantly reduced on days one and three when compared to day two (1096 109 (day 1) and 1116 108 (day 3) 3h pmol/liter vs